Primary record
7-(2-chlorophenyl)-9,13-dimethyl-4-{2-[4-(2-methylpropyl)phenyl]ethyl}-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0^{2,6}]trideca-2(6),4,7,10,12-pentaene
- 库存
- 1,815 克
- 纯度
- 99.5 %
- CAS
- 117279-73-9
化合物标识与属性
- CAS
- 117279-73-9
- PubChem CID
- 119175
- SMILES
- CC1C2=NN=C(N2C3=C(C=C(S3)CCC4=CC=C(C=C4)CC(C)C)C(=N1)C5=CC=CC=C5Cl)C
- Canonical SMILES
- Cc1nnc2n1-c1sc(CCc3ccc(CC(C)C)cc3)cc1C(c1ccccc1Cl)=NC2C
名称与同义词
- Israpafant
- Pafnol
- Israpafant [INN]
- Israpafant?
- 117279-73-9
- (+/-)-israpafant
- ISRAPAFANT [MI]
- UNII-O3MCV749SW
- AC1L3OBT
- ISRAPAFANT [JAN]
- RefChem:150178
- O3MCV749SW
- D0D4ZM
- Israpafant < Prop INN >
- C28H29ClN4S
- ISRAPAFANT [WHO-DD]
- Y-24180
- DTXSID5020312
- DTXCID10312
- SCHEMBL121588
- GTPL1857
- orb1700317
- 117279-73-9 (racemic)
- CHEMBL2107428
- SCHEMBL30733966
- C28-H29-Cl-N4-S
- Pafnol (Mitsubishi Pharma, JP)
- RMSWMRJVUJSDGN-UHFFFAOYSA-N
- Y 24180
- GLXC-05755
- SEA27973
- Tox21_113300
- CID119175
- MFCD00873428
- NCGC00183008-01
- AKOS040748599
- HY-106837
- J366.309D
- LS-185098
- CAS-117279-73-9
- CS-0026687
- NS00125048
- L000999
- 4-(2-Chlorophenyl)-2-(2-(4-isobutylphenyl)ethyl)-6,9-dimethyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine
- 4-(2-chlorophenyl)-2-(4-isobutylphenethyl)-6,9-dimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
- A1018180
- Q27881903
- (+-)-4-(2-chlorophenyl)-2-[2-(4-isobutylphenyl)ethyl]-6,9-dimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
- (+-)-4-(o-Chlorophenyl)-2-(p-isobutylphenethyl)-6,9-dimethyl-6H-thieno(3,2-f)-s-triazolo(4,3-a)(1,4)diazepine
- 4-(2-chlorophenyl)-6,9-dimethyl-2-{2-[4-(2-methylpropyl)phenyl]ethyl}-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
- 6H-Thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine, 4-(2-chlorophenyl)-6,9-dimethyl-2-(2-(4-(2-methylpropyl)phenyl)ethyl)-
- 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine, 4-(2-chlorophenyl)-6,9-dimethyl-2-[2-[4-(2-methylpropyl)phenyl]ethyl]-
- 7-(2-chlorophenyl)-9,13-dimethyl-4-[2-[4-(2-methylpropyl)phenyl]ethyl]-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene
- (+-)-(4)-(2-CHLOROPHENYL)-2-[2-(4-ISOBUTYLPHENYL)ETHYL]-6,9-DIMETHYL-6H-THIENO[3,2-f][1,2,4]TRIAZOLO[4,3-a][1,4]DIAZEPINE
- (+/-)-4-(O-CHLOROPHENYL)-2-(P-ISOBUTYLPHENETHYL)-6,9-DIMETHYL-6H-THIENO(3,2-F)-S-TRIAZOLO(4,3-A)(1,4)DIAZEPINE
- 4-(2-chlorophenyl)-2-[2 -(4-isobutylphenyl)ethyl]-6,9-dimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
- 4-(2-Chlorophenyl)-2-[2-(4-isobutylphenyl)ethyl]-6,9-dimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
- 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine,4-(2-chlorophenyl)-6,9-dimethyl-2-[2-[4-(2-methylpropyl)phenyl]ethyl]-
- 7-(2-chlorophenyl)-9,13-dimethyl-4-{2-[4-(2-methylpropyl)phenyl]ethyl}-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0^{2,6}]trideca-2(6),4,7,10,12-pentaene
- 7-(2-chlorophenyl)-9,13-dimethyl-4-{2-[4-(2-methylpropyl)phenyl]ethyl}-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene
- Rac-4-(2-Chlorophenyl)-2-[2-(4-isobutylphenyl)ethyl]-6,9-dimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine